Cat No.
CEI-1085
Description
AT-7519 is an orally bioavailable small molecule with potential antineoplastic activity.
Abbr
AT-7519(CDKs)
CAS No.
902135-91-5
Targets
CDKs
Chemical Name
4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide hydrochloride
M.Wt
418.71
Purity
> 95%
Storage
-20 centigrade
